Ally Bridge Group (NY) LLC Quant / Systematic

CIK: 0001822947 · Show all filings

Period: Q4 2025 (← Previous)

Filing Date: Feb 17, 2026

Total Value ($000): $95,991 (100.0% shares, 0.0% debt)

Holdings (18)

New Positions (10)

Exited Positions (16)

SLNO SOLENO THERAPEUTICS INC 17.6%
Value ($000) $16,900 Shares 250,000 Est. Cost $65.05 Unrealized -15.7%
MDGL MADRIGAL PHARMACEUTICALS INC 15.6%
Value ($000) $14,981 Shares 32,662 Est. Cost $373.08 Unrealized +36.9%
ASND ASCENDIS PHARMA A/S - ADR 10.6%
Value ($000) $10,155 Shares 51,080 Est. Cost $198.81 Unrealized
LENZ LENZ THERAPEUTICS INC 8.5%
Value ($000) $8,168 Shares 175,363 Est. Cost $27.20 Unrealized +7.2%
AMLX AMYLYX PHARMACEUTICALS INC 6.2%
Value ($000) $5,944 Shares 437,391 Est. Cost $9.41 Unrealized +44.3%
CMPS COMPASS PATHWAYS PLC 6.1%
Value ($000) $5,881 Shares 1,026,382 Est. Cost $2.80 Unrealized
PRAX PRAXIS PRECISION MEDICINES I 5.5%
Value ($000) $5,300 Shares 100,000 Est. Cost $186.22 Unrealized 0.0%
MNPR MONOPAR THERAPEUTICS INC 5.5%
Value ($000) $5,264 Shares 64,455 Est. Cost $40.21 Unrealized +103.2%
ARQT ARCUTIS BIOTHERAPEUTICS INC 4.6%
Value ($000) $4,396 Shares 233,220 Est. Cost $15.77 Unrealized +62.3%
MIND MEDICINE MINDMED INC 4.4%
Value ($000) $4,261 Shares 361,444 Est. Cost $7.76 Unrealized
TARS TARSUS PHARMACEUTICALS INC 4.4%
Value ($000) $4,206 Shares 70,778 Est. Cost $28.11 Unrealized +165.7%
PROMIS NEUROSCIENCES INC 2.8%
Value ($000) $2,649 Shares 6,233,497 Est. Cost $0.65 Unrealized
AVTX AVALO THERAPEUTICS INC 2.4%
Value ($000) $2,264 Shares 178,100 Est. Cost $8.60 Unrealized +96.3%
TECX TECTONIC THERAPEUTIC INC 2.3%
Value ($000) $2,175 Shares 138,595 Est. Cost $30.22 Unrealized -38.5%
MLTX MOONLAKE IMMUNOTHERAPEUTICS 0.5%
Value ($000) $495 Shares 69,000 Est. Cost Unrealized
ATYR ATYR PHARMA INC 0.5%
Value ($000) $433 Shares 600,000 Est. Cost Unrealized

Decreased Positions (7)

Unchanged Positions (1)